Alcon Seeks Quick Bangs For Its Buck In The Device Sector
This article was originally published in The Gray Sheet
Executive Summary
Alcon says it is looking to leverage short-term opportunities to grow its surgical business
You may also be interested in...
Alcon Expands Glaucoma Portfolio Into Surgical Devices With Optonol Buy
Alcon will enter the surgical glaucoma market with its acquisition of Israel-based Optonol, maker of miniature implants to reduce intraocular pressure
Alcon Expands Glaucoma Portfolio Into Surgical Devices With Optonol Buy
Alcon will enter the surgical glaucoma market with its acquisition of Israel-based Optonol, maker of miniature implants to reduce intraocular pressure
Abbott Gains Synchrony Accommodating IOL Via $400 Mil. Visiogen Purchase
Abbott will strengthen its premium intraocular lens offerings and enter the accommodating IOL market for the first time through its $400 million purchase of Visiogen, announced Sept. 2